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Abstract
Composition of gastrointestinal (GIT) microbiota differs in individual parts of GIT. Only 
40% of GIT bacteria are cultivable. Fluorescence-in-situ-hybridization (FISH) can detect 
non-cultivable bacteria. Perorally administered antibiotics (ATB) affect the composition 
of microbiota in GIT. The absorbed ATB, namely penicillins, tetracyclines, macrolides or 
fluorochinolons, have different influence in comparison with poorly absorbed oral ATB, 
such as aminoglycosides, aminocoumarines or polypeptides. This effect is due to reten-
tion of high concentration of non-absorbed ATB during passage through GIT and their 
longer influence on bacteria living in different parts of GIT. Study methods were based 
on scientific literature review from PubMed, Elsevier databases and Slovak scientific 
publications. We searched for publications between years 1980 and 2016, with keywords: 
ATB, influence, microbiota, FISH. The literature review focuses on peroral administration 
of ATB to humans and animals and its potential effect on composition of GIT microbiota. 
The relevant studies showed that per orally administered ATB produced many important 
changes in microbiota of GIT. FISH method was more frequently used for screening the 
normal composition of microbiota than for studying the effects of ATB although there 
were some studies dealing also with this issue.
Keywords: peroral ATB, effect, microbiota, GIT, FISH
1. Introduction
Although the use of antibiotics administered antibiotics (ATB) is nowadays often neces-
sary, there is still a number of issues that arise from their abuse. It is known, that excessive 
use of ATB has a negative impact on physiological composition of intestinal microbiota, 
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especially when they are administered per os. This is due to increase in gastrointestinal 
(GIT) diseases. To understand the impact of ATB on GIT microbiota it is necessary to 
know the correct composition of the GIT microbiota and changes induced by various ATB 
in this convocation. The most common pattern for tracking changes in the microflora is 
faeces. However, there is little knowledge on microbiological changes in various parts of 
GIT. Experimental animals, both conventional and gnotobiotic, were used in relevant stud-
ies. However, they were fed a different type of food in addition to a number of anatomi-
cal and physiological differences. Therefore, for many scientists this issue still remains a 
great mystery. Also, until the development of sensitive molecular methods, conventional 
culture methods were used to track these changes. However, since 40–90% of the intestinal 
bacteria are not cultivable, scientists looked for and tested more sensitive and accurate 
methods for the detection and quantification of microorganisms [1]. For example, devel-
oped were methods based on PCR-DGGE, real-time PCR, and others. However, even these 
methods have shortcomings that require an amplification process which may introduce an 
untargeted error. The fluorescent-in-situ-hybridization (FISH) method is independent of 
the amplification and is sufficiently sensitive to trap even non-cultivable microorganisms. 
So far scientists have used a number of FISH to determine the physiological composition 
of microbiota of GIT, either animal or human. In addition, the new development allows 
one to monitor potential changes under the impact of substances added to the diet in both 
experimental animals and clinical patients. The aim of this study was to summarise the 
findings on the impact of ATB on composition of intestinal microbiota by means of FISH 
method using available sources and compare them with previously published knowledge 
in this area. The importance of this study consists in finding out whether it is possible to 
track by this method the changes in GIT microbiota produced by ATB and thus contribute 
to the body of knowledge in this area.
Recently, the increasing resistance of bacterial agents to ATBs, such as Methicillin-resistant 
Staphylococcus aureus (MRSA) or Pseudomonas, stressed the importance of the development 
of novel ATB derivatives [2]. New classes of antibiotics are urgently needed to treat nosoco-
mial infections. The risk of increasing ATB resistance also increases due to the increased use 
of broad-spectrum ATBs in unprofessional human and veterinary clinical practice, without 
detecting the bacterial origin of the disease and its sensitivity to ATBs. ATB residues in food 
of animal origin from countries not complying with the 2006 EU Directive have an impact on 
the increased risk of spreading antibiotic resistance. Development of ATB-resistant strains can 
be prevented by using correct therapeutic dose of ATB and completing the prescribed course 
of treatment. Properly balanced intestinal microflora prevents the development of resistant 
microbial strains. Normal microbiota acts as a barrier against the colonisation of potentially 
pathogenic microorganisms and against the excessive growth of opportunistic microorgan-
isms already present. Administration of ATBs either therapeutically or as a prophylactic 
measure disturbs the ecological balance between the host and the normal microbiota. The 
clinically most common symptoms of intestinal microbiota disruption are diarrhoea and fun-
gal infections that usually resolve after the treatment has ended [3]. It is difficult to assess 
the long-term consequences of microbial symbiosis disorders in the intestine. In addition to 
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changes in intestinal microbiota, many chronic diseases such as asthma and atopic diseases 
are associated with the use of ATB in childhood [4].
2. Antibiotics
In 1928, Alexander Fleming discovered that the growth of Penicillium notatum suppressed 
the growth of staphylococci, and then, as this phenomenon was studied, it was found that 
the cause was an exoproduct of a mould called penicillin that was released into the cultiva-
tion medium. In 1938, Howard Florey and Ernst Chain began experimenting with penicil-
lin mould. By 1941, a sufficiently purified form of penicillin was obtained and by early 
1942, American pharmaceutical companies were mass producing penicillin for distribution 
to Allied soldiers during the Second World War [5]. Since the first effects of ATB have been 
discovered, other substances with ATB properties have appeared and many have found a 
wide range of applications in medicine for the treatment of infections caused by bacteria, 
pathogenic fungi, mycoplasmas, rickets, chlamydia and some other agents [6]. Attempts to 
influence GIT microbiota with ATB date back to the very beginning of their use. The impact 
of ATB was observed in clinical practice as well as during preoperative patient preparation. 
With regard to animal production, it raised interest particularly for economic reasons, as it 
was shown that ATBs accelerate the growth and weight gain in mice, dogs, but also in pigs 
and calves. Experiments on germ-free chickens revealed that the nutritional effect of ATB 
is mainly related to suppression of some subclinical infections [7].
Antibiotics are substances of organic origin produced by bacteria and moulds, possibly from 
higher plants or animal tissues, and can be prepared synthetically or semi-synthetically [8]. 
Their name was derived from the phenotype of Pasteur, which was described by Pasteur in 
the 1960s.
According to their biological effect on microorganisms they are divided to two groups, 
one with bacteriostatic action and another one with bactericidal effect. Bacteriostatic ATBs 
arrest multiplication of bacteria so the bacteria are not killed and natural dying of quiescent 
bacterial cells is not affected. Bactericidal effect of ATBs results in death of bacterial cells. 
The bactericidal effect during the first 4 hours of action of ATBs is of specific importance. 
If at least 99% of bacteria is killed within this time we can speak about clinically relevant 
bactericidal action.
ATBs are divided into 5 groups according to the mechanism of action:
1. Inhibition of cell wall synthesis (bactericidal effect), (typical of penicillins, vancomycin, 
cycloserin)
2. Effect of cell wall function (bactericidal effect), (typical of polymyxins)
3. Inhibition of protein synthesis (bacteriostatic and bactericidal effect) (chloramphenicol, tet-
racyclines, aminoglycosides, macrolide ATBs)
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4. Inhibition of nucleic acid synthesis (bactericidal effect), (griziofulvin, rifampicin)
5. Interference in the intermediary metabolism of bacteria (sulfonamides)
2.1. Oral antibiotics
Not all ATBs can be administered orally, but ATBs capable of influencing GIT microbiota must 
be available in the form suitable for oral administration. The most commonly used orally admin-
istered ATBs include: penicillins, cephalosporins, tetracyclines, polypeptide ATBs, aminoglyco-
sides, macrolides, Lincosamide ATB, ansamycin ATB, diterpenes, aminocoumarin ATBs, steroid 
antibiotics, sulfonamides and quinolones. Among these, we include the following representatives:
1. Penicillins:
(A) Phenoxypenicillins: Phenoxymethylpenicillin—Penicillin V, Penamecillin, Penetacil-
lin, Benetaminpenicillin, Phenticillin, Propicillin, Phenbenicillin, Klometocillin
(B) Wide spectrum of penicillins:
1. Aminopenicillins: Ampicillin, Bakampicillin, Pivampicillin, Talampicillin, Amoxi-
cillin, Epicillin, Cyclaclin
2. Carboxypenicillins: Carbenicillin Esters: Indanyl Carbenicillin, Carfecili
3. Amidopenicillins: Mecilinam esters: Bakmecilinam, Pivmecilinam
4. Isoxazolylpenicillins: Oxacillin, Dicloxacillin, Kloxacillin, Flucloxacillin, Pirazocillin
2. Cephalosporins: Cefalexin, Cefadroxil, Cefixim, Metacyclin, Tiacycline
3. Amphenicols: Chloramphenicol, Tiamfenicol, Florfenicol
4. Tetracyclines: Chlortetracycline, Oxytetracycline, Tetracycline, Doxycycline, Minocycline,
5. Polypeptide antibiotics: Polymyxins: Polymyxin B
6. Aminoglycosides: Streptomycin, Neomycin, Kanamycin, Apramycin, Gentamicin, To-
bramycin and Aminocyclitols: Spectinomycin
7. Macrolides: Erythromycin, Spiramycin, Tylozine, Oleandromycin, Troleandromycin, 
Josamycin, Tilmicosine, Clarithromycin, Roxithromycin and Azalides: Azithromycin
8. Linkozamide antibiotics: Linkomycin, Klindymycin
9. Ansamycin antibiotics: Rifampicins: Rifampicin, Rifaximin, Rifabutin, Rifapentin
10. Diterpenes: Tiamulin, Valnemulin
11. Aminocoumarin antibiotics: Novobiocin
12. Antibiotics with steroid structure: Fusidic acid
According to some authors, other peroral drugs with antibacterial activity are considered 
antibiotics:
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13. Other antimicrobials
1. Nitroimidazole derivatives: Metronidazole, Tinidazole Nimorazole
2. Sulfonamides:
Short-acting: Sulfathiazole, Sulfacetamide, Sulfisoxazole.
Medium-effective sulphonamides: Sulfadimidine, Sulfadiazine, Sulfamerazine, Sulfa-
methoxazole + Trimetoprim = Kotrixomazole, Sulfachloropyridazine.
Long-term effective: Sulfamethoxypyridazine, Sulfadoxine, Sulfadimetoxin Enteric-acting 
sulfonamides: Phthalylsulfathiazole, Succinylsulfathiazole, Sulfachinoxaline, Sulfaclozine
3. Quinolones: Nalidixic acid, Flumequin, Enrofloxacin, Difloxacin, Ciprofloxacin, Marbo-
floxacin, Norfloxacin, Sarafloxacin, Pefloxacin, Ofloxacin, Ibafloxacin, Orbifloxacin
3. Materials and methods
Search method: we searched the PubMed, and Elsevier databases and Slovak scientific litera-
ture for the studies dealing with the effect of ATBs on GIT composition. We searched for pub-
lications in the period from 1980 to 2016 using keywords related to ATB, Influence, microbiota, 
FISH. A literature review was produced aimed to identify association between peroral adminis-
tration of ATB to humans or animals and its effect on composition of normal microbiota in GIT.
4. Influence of ATB on GIT microflora
Administration of ATBs can seriously disturb the balance of the intestinal microbiota in terms 
of multiplication of bacteria and development of resistant microorganisms. This can lead to 
infections and to the transfer of resistance factors between bacteria [9]. According to the major-
ity of authors, the effect of ATB on nutrition is mediated by intestinal microbiota. Antibiotics 
are divided according to their effect on GI microbiota to ATBs capable of absorption across 
the intestinal wall and to those that cannot be absorbed at all or only in very small amounts. 
The lower the bioavailability of ATB the more it remains in the colon and thus the risk of sup-
pression of intestinal microflora increases. If ATBs are absorbable (e.g. tetracycline, penicillin, 
chloramphenicol, etc.), their concentration is lower in the GIT endpoints. In contrast, ATBs 
incapable of absorption (e.g. streptomycin, polymyxin, neomycin, etc.) may have a strong 
toxic effect on the microbiota throughout the GIT. The effect of ATB is generally dependent 
on the dose, the active substance, the duration of administration and other factors. The search 
results clearly demonstrated that the effect of ATB on the GIT microbiota is as follows:
1. Breach of microbial balance (in GIT, urinary tract, reproduction tract, etc.).
2. Vitamin K hypovitaminosis as result of long-term use ATB (especially p.o.)
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3. Resistance of resistant strains, superinfection: Candida, Staphylococcus, Pseudomonas, 
Clostridium difficile and others.
4. Evidence of rapid bacteriolysis, particularly Gram-negative bacteria (endotoxin release)
4.1. Testing of ATB effect on animals
The studies of the effect of ATB on microbiological-clinical microbiota date back more than 50 
years ago [10, 11]. The effect on microbiota was investigated with regard to the weight gains 
of conventional experimental animals. Studies on germ-free animals (without GIT microbes) 
showed weight gains related to ATB [11]. It is still an up-to-date topic as indicated by recent 
studies [12]. To demonstrate the presence of bacteria and changes in their numbers, whether 
under the influence of antibiotics and other substances, conventional cultivation methods 
are still used. However, these methods have recently been supplemented by more sensitive 
molecular methods. One of the methods used for quantification of bacterial population is the 
fluorescent-in-situ-hybridization method (FISH). These methods can be used to accurately 
identify and quantify the species representation of microorganisms [13]. While radioac-
tive labelling was previously used in the FISH methodology, today we use fluorochrome-
labelled probes [14]. The probes serve to specifically bind to that part of the target sequence 
that exhibits a high degree of sequence complementarity. The probes consist mostly of 15–30 
nucleotides and are covalently labelled with a fluorescent dye at the 5 ‘end—fluorescein, tetra-
methylrodamine, Texas red, carbocyanine. Up to now, several probes have been standardised, 
which are currently used to quantify the major intestinal bacteria (Table 1). For example, a 
probe called (S-G-Lab-0158-a-A-20) or abbreviated Lab158 is designed to detect the presence 
of Lactobacillus spp./Enterococcus spp. in the monitored samples. It is an oligonucleotide with 
the sequence 5’X-GGT AAT AGC A (T/C) C TGT TTC-3 ‘wherein X is fluorochrome [16]. This 
method is particularly useful in the study of the effect of probiotics, which are often required 
to identify probiotic bacteria of the commensal microflora [17]. Recently it was reported that 
the simultaneous use of ATB and supportive probiotic therapy, which can help to restore 
intestinal microbiota, can also expand the antibiotic resistance of bacterial intestinal bacteria 
[18, 19].
4.2. Changes in GIT miroflora after ATB treatment in laboratory animals by FISH 
methods
In addition to scientific papers dealing with the impact of antibiotics on the microflora of GIT 
by means of conventional culture methods, studies using FISH method were also published 
focusing mainly on quantification of bacterial representatives in samples of various origin. 
This later led to the use of this method also for the purpose of monitoring the effect of ATB on 
the GIT microflora not only in humans [20] but also in experimental animals that were used 
to determine changes in composition of microbiota. For example, using of FISH for research 
of effect of amoxicillin potentiated by clavulanic acid on human faecal microflora in germ-free 
mice [21]. To provide more clear overview, the sources obtained by search were divided on 
the basis of their ability to absorb across the GIT.
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4.2.1. Absorbable ATBs
4.2.1.1. Penicillin ATBs: aminopenicillins
4.2.1.1.1. Amoxicillin
The results of studies dealing with the effect of amoxicillin on the microbiota indicate that per os 
administration caused a significant decrease in the number of total faecal bacteria by almost 30%, as 
determined by the universal Eub338 probe. Major microbiota populations such as Fusobacterium, 
Short name Full name Target microorganism Sequences (5′ - 3′)
Sal 303 L-S-Sal-1717-a-A-18 Salmonella spp. AATCACTTCACCTACGTG
Bif164 S-G-Bif-0164-a-A-18 Bifidobacterium spp.,
Parascardovia denticolens
CATCCGGCATTACCACCC
Lab158 S-G-Lab-0158-a-A-20 Lactobacillus,
Weissella spp.; Lactococcus lactis;
Vagococcus, Enterococcus,
Melisococcus, Tetragenococcus,
Catellicoccus, Pediococcus a
Paralactobacillus spp.
GGTATTAGCAYCTGTTTCCA
Bac303 S-Bacto-0303-a-A-17 Bacteroides sensu stricto, Prevotella 
spp., Parabacteroides;
Barnesiella viscericola a
Odoribacter splanchnicus
CCAATGTGGGGGACCTT
Chis150 S-Chis-0150-a-A-23 Clostridium tyrobutyricum;
Adhaeribacter aquaticus, 
Flexibacter canadensis, 
Flexibacteriaceae;
Propionibacteriaceae
TTATGCGGTATTAATCTYCCTTT
Rbro730 S-Rbro-730-a-A-18 Ruminococcus bromii-like;
Clostridium sporosphaeroides a
Clostridium leptum
TAAAGCCCAGYAGGCCGC
Rfla729 S-Rfla-729-a-A-18 Ruminococcus albus a
Ruminococcus flavefaciens
AAAGCCCAGTAAGCCGCC
Ato291 S-Ato-0291-a-A-17 Atopobium, Colinsella, Olsenella 
Eggerthella spp.; Cryptobacterium 
curtum; Mycoplasma equigenitalium
Mycoplasma elephantis
GGTCGGTCTCTCAACCC
Erec482 S-Erec-0482-a-A-19 Clostridium saccharolyticum, 
Syntrophococcus sucromutans,
Bacteroides galacturonicus  
Bacteroides xylanolyticus 
Lachnospira pectinschiza
GCTTCTTAGTCARGTACCG
Source: http://onlinelibrary.wiley.com/doi/10.1111/j.1574-6941.2008.00610.x/pdf
Table processed by the author from the original Table [15].
Table 1. Probes for FISH analysis used to detect bacterial populations in samples from in vitro fermentation.
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Eubacterium and Atopobium were affected by amoxicillin. There was observed also a percent-
age increase in Bacteroides and Bifidobacterium. The results also showed that not all evaluated 
populations were affected by the ATB. The greatest change was observed in E. coli counts, which 
increased significantly during ATB administration [3, 22]. By using FISH, the effect of amoxicil-
lin potentiated by clavulanic acid on human faecal microbiota in germ-free mice was observed 
[21]. In this study, amoxicillin with clavulanic acid was administered orally for 7 days and the 
results were compared with the control group of mice not treated with ATB. Molecular analy-
sis of digestive microbiota was performed in a 2-week experiment using FISH in combination 
with flow cytometry (FC) using specific 16S rRNA target probes for Bacteroides-Porphyromonas-
Prevotella, Clostridium coccoides-Eubacterium rectale, Clostridium histolyticum, Faecalibacterium 
prausnitzii, Enterobacteriaceae, Lactobacillus, Enterococcus, and Bifidobacterium. Clostridium coccoides-
Eubacterium rectale and Bacteroides-Porphyromonas-Prevotella, which represented the dominant 
flora, were found to be the most abundant bacterial groups. The Clostridium coccoides group was 
stable in control mice (from 40.7 ± 1.6% to 45.6 ± 2.8%) but significantly decreased in the treated 
mice on the second day of treatment and remained at a low level throughout the ATB treatment 
(3.9 ± 0.8%). At the end of ATB administration, the levels increased (17.7 ± 4.7%) and by day 14 
reached 36 ± 1.8%. The Bacteroides-Porphyromonas-Prevotella group in control mice persisted at 
35.9 ± 4.3%, whereas in treated mice it increased from 1 to 6 days when it reached 58.5 ± 0.4.5%. 
From day 9, the level decreased to 38.6 ± 5.7% until it reached the same level as in control mice at 
the end of the experiment [21]. This animal model allowed the authors to conclude that amoxi-
cillin potentiated by clavulanic acid disrupts the balance of the dominant anaerobic microflora 
and that the Clostridium coccoides group is very susceptible to amoxicillin potentiated by clavu-
lanic acid. No Enterobacteriaceae bacteria were detected in control mice, on the other hand their 
number increased and they were detectable in the treated mice from day 2 of administration of 
ATB. From day 8, their counts decreased and from day 11 until the end of the experiment they 
were no more detectable. Faecalibacterium prausnitzii and Clostridium histolyticum were present 
in 1.3 ± 2.1% and 0.4 ± 0.4% of control mice [21]. No bacteria were detected in the treated mice 
during administration of ATB, i.e. these bacterial groups were sensitive to amoxicillin-clavulanic 
acid. From day 1 to day 14 after administration of ATB, the counts of these groups of bacteria 
were similar to those in control mice. The probes for Bifidobacterium, Lactobacillus and Enterococcus 
did not detect any signals in either treated or control mice [21]. During 7 days of per os treatment 
with amoxicillin potentiated with clavulanic acid, the effect of Saccharomyces boulardii yeasts on 
the composition of intestinal microbiota in mice associated with human microbiota was also 
investigated. The predominant groups of bacteria were quantified by FISH in combination with 
flow cytometry. Probes for Eubacteria, Bacteroides-Porphyromonas-Prevotella, Clostridium coccoides-
Eubacterium rectale, Faecalibacterium prausnitzii, Clostridium histolyticum, Lactobacillus-Enterococcus, 
Enterobacteriaceae and Bifidobacterium species have been used. The observed mice were divided 
into two groups of mice, the first group received yeast and the second did not. In the second group 
the level of Enterobacteriaceae and Bacteroides increased but the numbers of C. coccoides-E rectale 
dropped dramatically. After ATB treatment, the original intestinal flora was restored more rap-
idly for C. coccoides-E. rectale and Bacteroides-Porphyromonas-Prevotella in S. boulardii mice versus 
control mice (p < 0.05) [21]. The effect of other beta lactam ATBs on the microbiota, in particular 
of imipenem, was also observed using the FISH method (Dubourg et al., [23]). The susceptibility 
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of Akkermansia muciniphila with respect to the effect of imipenem was also studied. In this case, 
the FISH method utilised a specific protozoan 5 ‘[Alexa488/546] GCTGCCACCCGTAGGTGT 
for Verrucomicrobium, which confirmed the presence of the bacterium. EUB338 ‘[Alexa488/546] 
5-GCTGCCTCCCGTAGGAGT-3 [23] was also used. Stool samples with Akkermansia muciniphila 
were susceptible to imipenem.
4.2.1.2. Lincosamide ATBs
4.2.1.2.1. Clindamycin
Clindamycin was used in the study dealing with development of vancomycin-resistant 
enterococci (VRE) because this ATB inhibits anaerobes in the intestine without the reduction 
of facultative Gram-negative bacilli and VRE [24]. It has been shown that clindamycin causes 
VRE growth in mice and colonised patients [25]. In this study, a mouse model was used to 
test the hypothesis that the anaerobic microflora in the large intestine inhibits development of 
vancomycin-resistant enterococci. Anaerobic growth of VRE was assessed in the caecal con-
tent and cervical mucus of mice receiving subcutaneous clindamycin and in negative control 
administered saline solution. Following orogastric inoculation of VRE-Enterococcus Faecium 
C68, the mice were sacrificed and tested. To confirm that some Gram-positive cocci visualised 
in this experiment using light microscopy, a specific commercially available kit for the detec-
tion of E. faecium by fluorescence in situ hybridization (Microscreen) was used with E. faecium. 
In saline treated mice, no E. faecium was detected by in situ hybridization. In contrast, the 
presence of E. faecium was confirmed in clindamycin-treated mice [25].
4.2.1.3. Fluorochinolons
4.2.1.3.1. Ciprofloxacin
In a study investigating the role of intestinal bacteria in the pathogenesis of chronic, 
immuno-mediated inflammation of the intestine, ciprofloxacin has been shown to affect 
the inflammation of the intestine but not the inflammation of the colon. This has confirmed 
the selective effect of ciprofloxacin in the gut. Experimental pathogen free (SPF) mice were 
used. Furthermore, mice lacking the gene encoding interleukin 10 (IL10) producing colitis 
have been used. However, this does not occur in germ-free mice. Germ-free, IL-10 defi-
cient mice were colonised by SPF bacteria, and narrowed and broad-spectrum ATBs were 
observed to influence the development and development of intestinal inflammation in IL10 
deficient mice. ATBs were administered to mice orally, either preventively prior to colo-
nisation of SPF with bacteria or therapeutically. Quantitative bacterial analysis using the 
FISH method used parts of the blind and the colon [26]. BAC303 for Bacteroides/Prevotella, 
E. coli specific EC1531 and other Enterobacteriaceae, Lab158 for the detection of lactoba-
cilli and enterococci were used for FISH detection. By the FISH method, ciprofloxacin was 
found to reduce total aerobic bacteria in both the colon and caecum. E. coli was not detect-
able and the number of luminal enterococci was reduced. Reduction of lactobacilli was also 
confirmed [26].
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4.2.1.4. Other antimicrobial substances: imidazole derivatives
4.2.1.4.1. Metronidazole
A study [26] on germ-free, IL10 deficient mice that were colonised by SPF bacteria (no spe-
cific pathogens) and were monitored for the effect of a particular narrow spectrum ATB met-
ronidazole on the development of inflammation of the intestine showed a selective effect 
of metronidazole in the large intestine. The effect of this ATB on inflammation of the cer-
vix was not confirmed. BAC303 for Bacteroides/Prevotella, E. coli specific EC1531 and other 
Enterobacteriaceae, Lab158 for the detection of lactobacilli and enterococci were used for FISH 
detection. Metronidazole is selectively effective against anaerobic bacteria, including predom-
inantly Bacteroides. FISH revealed that administration of metronidazole reduced the number 
of Bacteroides species to a detectable level. Also, the amount of luminal E. coli was significantly 
reduced. FISH analysis showed that metronidazole had no significant effect on intestinal lac-
tobacilli. Enterococci were confirmed, in particular E. faecalis. The study [23] confirmed that 
Akkermansia muciniphila were resistant to metronidazole.
4.2.1.5. Tetracycline ATBs
4.2.1.5.1. Tetracycline
ATBs such as tetracycline have the ability to interfere with bacterial populations in the gut. If 
the formation of a microbial barrier against pathogens and potential pathogens is impaired, it 
can lead to the proliferation of undesirable microorganisms such as Candida albicans. In in vitro 
studies, growth of C. albicans was observed in growth media in the presence of tetracycline, 
with a significant increase in C. albicans. The potency of the probiotic culture of Lactobacillus 
plantarum LPK, which was added to the in vitro fermentation system, was also tested to deter-
mine whether this organism had any effect on the Candida population. Although C. albicans 
was not completely removed in the presence of this bacterium, its numbers were significantly 
reduced. This study showed that the use of probiotics, in particular Lactobacillus plantarum, 
had a positive effect on the reduction of undesirable C. albicans, the number of which was 
increased by tetracycline administration. It also pointed out that normal intestinal microflora 
can itself develop a ‘natural’ resistance to C. albicans (Payne et al., [27]). In the future, it would 
be necessary to use a probe detecting the presence of C. albicans to quantify this bacterium 
when studying the effect of tetracycline on GIT microbiota. For this purpose, oligonucleotide 
020 (5 ‘CCCCCTTTCCTAAACCAATCCGGA 3’) can be used [28].
4.2.1.5.2. Doxycycline
One of the few studies that dealt with the effect of doxycycline on microbiota using the FISH 
method was a study aimed at monitoring its effect on Akkermansia muciniphila. For the FISH 
method, a specific probe 5 ‘[Alexa488/546] GCTGCCACCCGTAGGTGT for Verrucomicrobium 
was used to confirm the presence of the bacterium. Also, EUB338 ‘[Alexa488/546] 5-GCTG-
CCTCCCGTAGGAGT-3 [22] was used. In the stool specimen with Akkermansia muciniphila, 
the sensitivity of this bacterium to doxycycline was confirmed.
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4.2.2. Not resorbing ATB
4.2.2.1. Aminoglycoside ATB
4.2.2.1.1. Streptomycin
In streptomycin-treated conventional mice most of the facultatively aerobic Gram-negative 
rods, amounting to about 0.1 to 1% of microbiota, were eliminated by streptomycin treat-
ment [29]. Multiple model experiments were used to study the effect of streptomycin on 
microbiota of mice. To detect the presence and quantify E. coli strains in streptomycin-treated 
mice, the authors used ribosomal probe ES 1531 specific for E. coli 23S rRNA and E. coli BJ4 
reference strain that was detected in stool samples [29]. Also, the adhesion properties of E. 
coli to colonic mucosa were studied in streptomycin-treated mice and reduced numbers of 
E. coli were detected [30]. Sekirov 2008 used for the study of the effect of streptomycin on 
the intestinal microbiota the EUB338 mouse probe for all bacteria (Eubacteriaceae) with the 
sequence (5 ‘[TxRd]-GCT GCC TCC CGT AGT AGG-3’), Cytophaga-Flavobacterium-Bacteroides 
CFB286 ‘[Fluorescein]-TCC TCT CAG AAC TAC CCC-3’) and for the Gammaproteobacteria 
probe GAM42a (5 ‘fluorescein-GCC TTC CCA CAT CGT TT-3’). Sekirov investigated the abil-
ity to produce Salmonella infection after ATB treatment [31]. He demonstrated that after the 
administration of streptomycin, the equilibrium of the microbial community of the intestine 
changes, giving the possibility of infection with Salmonella. He also found that increasing 
doses of streptomycin resulted in a gradual increase in the strains of Firmicutes and Cytophaga-
Flavobacterium-Bacteroides (CFB). At the genus level, the numbers of lactobacilli and entero-
cocci/group D streptococci decreased significantly. Gradually, the number of Firmicutes and 
other bacteria was reduced. Sekirov, however, concluded that ATB treatment changes the 
composition of intestinal microbiota depending on dose and type of ATB, but does not sig-
nificantly change the total number of gut microbiota [31]. After 8 days of per oral administra-
tion, the use of a combination of streptomycin and penicillin caused a significant reduction 
in all bacterial counts measured by FISH and intestinal content analysis (Swann et al. [32]). 
Although almost every ATB treatment induces an increase in pathogenic colonisation, the 
development of enterocolitis was particularly observed after the use of streptomycin or van-
comycin (Ferreira et al. [33]). In the current research, three types of mouse models were used 
to study the interaction between the host and the given bacterium: gnotobiotic, conventional 
and streptomycin-treated. Studies have shown that mice pre-treated with ATBs (e.g. strepto-
mycin) have a higher chance of competitive growth of intestinal pathogens in the intestine, 
although the mechanism is poorly elucidated [34]. Streptomycin-treated mice are the best 
model for studying the growth and survival of extraneous microorganisms in the intestine 
without causing pathogenesis [35].
4.2.2.2. Macrolide ATBs
4.2.2.2.1. Erythromycin
Using a FISH method, a study was conducted that investigated the resistance of the Campylobacter 
strain to macrolide ATB erythromycin. This strain is the most common cause of inflammation 
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of the intestines (enteric). Because its resistance to quinolones rises, macrolides are currently 
the drug of first choice. In humans, the resistance of Campylobacter to macrolides is about 5%, 
but in some animals it is up to 80%. Probes for the detection of macrolide resistance in H. pylori 
were used [36, 37]. The theoretical applicability of these probes for Campylobacter was assessed 
by controlling previous publications [38, 39]. FISH may also be useful for detecting macrolide 
resistance in other bacteria, e.g. mycobacteria or haemophiliacs. However, for this purpose, 
probes must be adapted to different sequences accompanying the mutation point [40].
4.2.2.2.2. Clarithromycin
The effect of clarithromycin as the most commonly used ATB for the treatment and eradi-
cation of Helicobacter pylori was studied using the FISH method [36]. In this study, FISH 
methods were used to demonstrate the presence of H. pylori and to identify the 23S rRNA 
spot mutation responsible for macrolide resistance directly from a biopsy specimen. All 
oligonucleotide probes used in this study were previously described and evaluated [41]. 
Briefly, the HPY-1 (5′-CACACCTGACTGACTATCCCG-3′) probe targeting 16S rRNA was 
used to identify H. pylori, while the ClaR1 (A2143G) (5′-CGGGGTCTTCCCGTCTT-3′), ClaR2 
(5′-CGGGGTCTCTCCGTCTT-3′) and ClaR3 (A2143C) (5′-CGGGGTCTTGCCGTCTT-3′) were 
used to detect the 23S rRNA spot mutation responsible for the resistance of the bacterium to 
clarithromycin. A ClaWT probe (5′-CGGGGTCTTTCCGTCTT-3′) was also used to identify 
H. pylori strains sensitive to clarithromycin that were not detected either by ClaR1, ClaR2 or 
ClaR3. Similar studies have also been addressed [42].
4.2.2.3. Glycopeptide ATBs
4.2.2.3.1. Vancomycin
In mice, the effect of vancomycin on GIT microbiota differs significantly from that of streptomycin 
[31]. Low doses of vancomycin reduce bacterial counts of Firmicutes and Cytophaga-Flavobacterium-
Bacteroidetes (CFB) strains and cause a small increase in the class of Gammaproteobacteria. Higher 
doses of vancomycin already cause an increase in thecounts of Gammaproteobacteria, to nearly 
50% of the total microflora, while the counts of CFB remain reduced. The genera Lactobacillus-
Enterococcus, group D streptococci, are affected by the overgrowth of the Enterobacteriaceae and 
cultivated aerobic bacteria. ATB treatment alone does not cause significant changes in the total 
number of microbes, although vancomycin administration has a much greater effect on GIT 
microbiotas than streptomycin [31]. In the study by [43], the broad-spectrum vancomycin-imi-
penem combination was shown to be effective in mice, both in the cecum and in the colon. 
Despite the significant decrease in E. coli and E. faecalis, the total aerobic microflora was not 
reduced after administration of vancomycin with imipenem. However, the amount of total 
anaerobic bacteria was significantly reduced. Lactobacilli were eliminated after administration 
of the vancomycin-imipenem combination. Using FISH, it has also been found that by admin-
istering this combination, many Bacteroides species have been reduced below a detectable level 
[43]. Also, vancomycin resistance was investigated in Akkermansia muciniphila [23].
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